We will come together to support the first ever
Mark your calendar for the 6th of June 2025,
and join us in the efforts to support
the rare patient community and advance
the Global Collagen VI Network.
Participation and support are so crucial.
As owners of TruckSimFM Ajax & Pixie have a little boy called Ollie who has this very condition called Ulrich Muscular dystrophy so raising awareness and donation and supporting the charity in the just giving link will hopefully raise vital funds to finding a cure and it takes us one step closer to helping thousands of other col 6 patients around the globe.
A diagnosis of a rare disease from
COL6 deficiency is an extremely
difficult experience that puts even
the strongest person in the world
in a vulnerable condition.
Ullrich Muscular Dystrophy,
Bethlem Myopathy, Myosclerosis
and intermediate forms are
caused by mutations in the
COL6A1, COL6A2, COL6A3 genes.
Inheritance may be autosomal dominant or recessive.
Although precise incidence data
are lacking, the prevalence of
Ullrich CMD is 0.13 cases per 100,000
of the population,
and that of Bethlem myopathy
is 0.77 cases per 100,000.
72,900 cases globally estimated.
Pathogenic mechanisms: mitochondrial
dysfunction, where impaired mitochondria
fail to generate energy, leading to muscle
cell death, and autophagy deficiency,
which prevents the cell from eliminating
damaged components, further
aggravating mitochondrial damage.
Cyclosporine A corrected mitochondrial
dysfunction by increasing muscle
regeneration and strength.
A pharmacological low-protein diet
activated autophagy in muscle and
leukocytes, leading to improvements in
some functional tests, muscle strength,
and respiratory function.
Gene therapy is an innovative
approach, currently in the research and
development phase, aimed at
correcting mutations, inhibiting or
replacing defective genes with the
correct ones, restoring cellular health
and function.
Please if you can donate to the below link Genetic Alliance UK